Stephen Squinto, Ph.D
Position: Executive Vice President, Chief Global Operation Officer, Co-founder
Prior to Alexion: Regeneron Pharmaceuticals, Assistant professor of Biochemistry and Molecular Biology at Louisiana State University Medical centre.
Education: BSc in Chemistry and Ph.D. in Biochemistry and BioPhysics from Loyola University, Chicago.
Dr. Squinto has held a number of leadership positions since co-founding the company in 1992, including the position as Head of R&D through which he oversaw the approval of Soliris for aHUS in both the US and Japan.
During his career, Dr Squinto has become a promenant researcher in molecular and cellular biology, with more than 70 papers resulting from his work. Dr. Squinto also serves on the Board of directors of the regional chapter of the Juvenile Diabetes Research Foundation.